SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-041078
Filing Date
2022-03-31
Accepted
2022-03-31 16:31:29
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B5 tm2210610d1_424b5.htm 424B5 624718
2 GRAPHIC sls_logo.jpg GRAPHIC 38161
3 GRAPHIC tm2210610d1_424b5img001.jpg GRAPHIC 28230
4 GRAPHIC tm2210610d1_424b5img002.jpg GRAPHIC 75712
5 GRAPHIC tm2210610d1_424b5img003.jpg GRAPHIC 82326
6 GRAPHIC tm2210610d1_424b5img004.jpg GRAPHIC 217632
7 GRAPHIC tm2210610d1_424b5img005.jpg GRAPHIC 105567
8 GRAPHIC tm2210610d1_424b5img006.jpg GRAPHIC 131995
9 GRAPHIC tm2210610d1_424b5img007.jpg GRAPHIC 239522
  Complete submission text file 0001104659-22-041078.txt   1893175
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255318 | Film No.: 22793119
SIC: 2834 Pharmaceutical Preparations